Market revenue in 2023 | USD 209.2 million |
Market revenue in 2030 | USD 443.9 million |
Growth rate | 11.3% (CAGR from 2023 to 2030) |
Largest segment | Direct fluorescent antibody (dfa) method |
Fastest growing segment | Direct Fluorescent Antibody (DFA) Method |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Direct Fluorescent Antibody (DFA) Method |
Key market players worldwide | Becton Dickinson & Co, Novartis AG ADR, Abbott Laboratories, QuidelOrtho Corp, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Roche Holding AG ADR, BioMerieux SA, Diasorin SpA, Merck KGaA, Avacta Group PLC, Siemens Healthineers AG ADR, Quest Diagnostics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to respiratory syncytial virus diagnostics market will help companies and investors design strategic landscapes.
Direct fluorescent antibody (dfa) method was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Asia Pacific respiratory syncytial virus diagnostics market based on direct fluorescent antibody (dfa) method covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific respiratory syncytial virus diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific respiratory syncytial virus diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account